Prescription of Aspirin and Statins in Primary Prevention.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 30704653.
- Also identified by DOI 10.1016/j.pop.2018.10.004.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The increasing burden of cardiovascular disease worldwide, including the United States, underscores the need for the more widespread use of adjunctive drug therapies of proven net benefit in the primary prevention of cardiovascular disease. These include aspirin to reduce mortality from cardiovascular disease, statins to lower LDL-cholesterol levels, appropriate use of multiple antihypertensive drug therapies to lower blood pressure, and aggressive multifactorial management of diabetes. This article reviews randomized evidence to provide guidance to primary care providers regarding the use of adjunctive drug therapies.
Medical subject headings
- Aspirin
- Cardiovascular Diseases
- Hydroxymethylglutaryl-CoA Reductase Inhibitors